Skip navigation

China National Accord Medicines Co. Ltd.

Pharmaceuticals
China
2016 Revenue (US$ Millions)$5,940
Revenue Growth (%)58.69%
Net Income (US$ Millions)$171
Earnings Per Share (US$)$0.40
EPS Growth Rate (%)33.33%
Profit Margin2.88%
Total Equity (US$ Millions)$1,217
Return on Equity (%)21.76%
Long Term Debt (US$ Millions)$0
Debt To Equity Ratio (%)0.00%
Total Assets (US$ Millions)$3,069
Current Assets (US$ Millions)$2,547
Current Liabilities (US$ Millions)$1,748
Cost of Goods Sold (US$ Millions)$5,278
Inventory Turnover11.13